RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical...
Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business...
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Taproot is pleased to announce the election of Leslie Hardy, Director of Inclusion and...
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Automated Microscopy...
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market...
Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today...
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global pharma e-commerce market...
PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy,...
Premise's Digital Wellness Center is the first virtual platform to receive accreditation from AAAHC BRENTWOOD, Tenn., Oct. 1, 2024 /PRNewswire/...
DALLAS, Oct. 1, 2024 /PRNewswire/ -- Scout, a leader in services and technology for the biopharmaceutical industry, announces the appointment of...
Dr. Shakthi Kumar, an industry leader in Life Sciences and Healthcare, has joined EDETEK's executive leadership team. Dr. Kumar will...
BERKELEY HEIGHTS, N.J., Oct. 1, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the...
Progressive Care Stock to Cease Trading Today, October 1, 2024 COCONUT GROVE, Fla., Oct. 1, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ:...
CHADDS FORD, Pa., Oct. 1, 2024 /PRNewswire/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory...
Expanded European presence aims to meet increasing global demand from the life science industry. RED BANK, N.J., Oct. 1, 2024...
Obesity: Phase 2 Clinical Study with Melanocortin-4 Receptor (MC4R) Agonist plus Glucagon Like Peptide-1 (GLP-1)Patient Dosing Commenced 3Q Calendar Year...
- Phase 1 clinical trial for smoking cessation expected to dose first patient in 4Q 2024 - - The study...
Meeting patient demand for breakthrough drugs and therapies requires new efficiencies on the manufacturing floor, and the industry is responding...
QUÉBEC CITY, Oct. 1, 2024 /PRNewswire/ - OPTEL, a global leader in traceability and vision systems, and Worximity, a leading...